FDA okays first drug made to reduce excessive sweating

BY LINDA A JOHNSON

Sunday, July 01, 2018

Print this page Email A Friend!


US regulators on Friday approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives.

The Food and Drug Administration approved Qbrexza for excessive underarm sweating, which will be available in October. The drug is inside a cloth wiped over the skin daily to block sweat glands from activating.

Its manufacturer, Dermira Inc, refused to disclose the price, as drug-makers normally do.

An estimated 15.3 million Americans have some form of excessive sweating, but only one in four get treatment. Current treatment options include Botox injections, surgery to remove sweat glands, procedures using lasers and other devices, and drugs approved for other conditions that block the body's chemical messengers in order to reduce sweat production throughout the body.

Side effects of Qbrexza include blurred vision, constipation, burning and itchy skin, head and throat pain, and dry mouth, eyes and skin.

Dermira said in one study, 53 per cent of patients reported Qbrexza reduced sweat production by roughly half, versus 28 per cent in a comparison group using a non-medicated cloth.

— Associated Press

ADVERTISEMENT




POST A COMMENT

HOUSE RULES

1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed: advertising@jamaicaobserver.com.

6. If readers wish to report offensive comments, suggest a correction or share a story then please email: community@jamaicaobserver.com.

7. Lastly, read our Terms and Conditions and Privacy Policy



comments powered by Disqus
ADVERTISEMENT

Poll

ADVERTISEMENT
ADVERTISEMENT

Today's Cartoon

Click image to view full size editorial cartoon
ADVERTISEMENT